Shield Therapeutics plc (AIM:STX)

London · Delayed Price · Currency is GBP · Price in GBX

3.950

-0.450 (-10.23%)

Jul 31, 2026, 5:06 PM GMT

Shield Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	49.7	49.7	32.18	13.09	5.5	2.05
Revenue Growth	19.78%	54.45%	145.93%	137.95%	167.76%	-85.54%
Gross Profit	23.04	23.04	14.93	4.03	2.46	0.73
Operating Income	-5.79	-10.05	-22.87	-31.33	-49.75	-27.44
Net Income	-17.66	-17.66	-27.18	-33.29	-49.79	-26.6
Earnings Per Share	-0.02	-0.02	-0.03	-0.05	-0.21	-0.14
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
The Netherlands	2.76	2.76	2.14	1.5	1.78	1.23
Canada	0.83	0.83	0.32	-	0.19	-
South Korea	-	-	0.12	0.02	0.01	0.74
Japan	0.34	0.34	0.32	-	-	-
United States	45.78	45.78	29.27	11.57	3.53	0.08
Total	49.7	49.7	32.18	13.09	5.49	2.06

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	11.62	11.62	6.52	13.95	3.4	16.35
Total Debt	30.14	30.14	26.37	20.25	6.79	0.21
Net Cash (Debt)	-18.51	-18.51	-19.85	-6.3	-3.39	16.14
Net Cash Growth	-	-	-	-	-	305.27%
Net Cash Per Share	-0.02	-0.02	-0.03	-0.01	-0.01	0.08

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-3.38	-3.38	-6.77	-37.13	-22.59	-24.69
Capital Expenditures	-0.02	-0.02	-0.04	-0.24	-0.06	-0.5
Free Cash Flow	-3.4	-3.4	-6.81	-37.37	-22.66	-25.19
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	46.36%	46.36%	46.40%	30.78%	44.70%	35.48%
Operating Margin	-11.65%	-20.22%	-71.08%	-239.44%	-904.75%	-1336.01%
Pretax Margin	-34.49%	-34.49%	-82.52%	-247.42%	-897.31%	-1310.53%
Profit Margin	-35.52%	-35.52%	-84.47%	-254.44%	-905.42%	-1295.46%
FCF Margin	-6.85%	-6.85%	-21.15%	-285.56%	-411.98%	-1226.73%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	113.42	113.42	113.42	113.42	113.42
PS Ratio	1.14	2.85	1.10	5.10	4.02	63.24